The rate of mpox infection in the vaccinated group was 0.09 for every 1,000 person-days as compared to 0.20 in the unvaccinated group. Thus, the estimated vaccine effectiveness with a single dose of the MVA-BN vaccine was 58%.

The African health agency says that Rwanda has started a vaccination campaign against mpox with 1,000 doses it obtained from Nigeria. Dr.

Rwanda has launched the first mpox vaccination campaign in Africa, marking a significant step in the continent’s fight against the disease. As of Tuesday, the country administered 300 doses of the vaccine to high-risk individuals in a border region with the Democratic Republic of Congo (DRC).